Cedar Clinic Limited 05971689 false 2024-07-01 2025-06-30 2025-06-30 The principal activity of the company is that of a dental practice Digita Accounts Production Advanced 6.30.9574.0 true true 05971689 2024-07-01 2025-06-30 05971689 2025-06-30 05971689 bus:OrdinaryShareClass1 2025-06-30 05971689 core:CurrentFinancialInstruments 2025-06-30 05971689 core:CurrentFinancialInstruments core:WithinOneYear 2025-06-30 05971689 core:Non-currentFinancialInstruments 2025-06-30 05971689 core:Non-currentFinancialInstruments core:AfterOneYear 2025-06-30 05971689 core:Goodwill 2025-06-30 05971689 core:FurnitureFittingsToolsEquipment 2025-06-30 05971689 core:OtherPropertyPlantEquipment 2025-06-30 05971689 1 2025-06-30 05971689 2 2025-06-30 05971689 bus:SmallEntities 2024-07-01 2025-06-30 05971689 bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 05971689 bus:FilletedAccounts 2024-07-01 2025-06-30 05971689 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 05971689 bus:RegisteredOffice 2024-07-01 2025-06-30 05971689 bus:Director1 2024-07-01 2025-06-30 05971689 bus:Director3 2024-07-01 2025-06-30 05971689 bus:OrdinaryShareClass1 2024-07-01 2025-06-30 05971689 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 05971689 core:Goodwill 2024-07-01 2025-06-30 05971689 core:FurnitureFittings 2024-07-01 2025-06-30 05971689 core:FurnitureFittingsToolsEquipment 2024-07-01 2025-06-30 05971689 core:OfficeEquipment 2024-07-01 2025-06-30 05971689 core:OtherPropertyPlantEquipment 2024-07-01 2025-06-30 05971689 core:PlantMachinery 2024-07-01 2025-06-30 05971689 1 2024-07-01 2025-06-30 05971689 2 2024-07-01 2025-06-30 05971689 countries:EnglandWales 2024-07-01 2025-06-30 05971689 2024-06-30 05971689 core:Goodwill 2024-06-30 05971689 core:FurnitureFittingsToolsEquipment 2024-06-30 05971689 core:OtherPropertyPlantEquipment 2024-06-30 05971689 2023-07-01 2024-06-30 05971689 2024-06-30 05971689 bus:OrdinaryShareClass1 2024-06-30 05971689 core:CurrentFinancialInstruments 2024-06-30 05971689 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 05971689 core:Non-currentFinancialInstruments 2024-06-30 05971689 core:Non-currentFinancialInstruments core:AfterOneYear 2024-06-30 05971689 core:Goodwill 2024-06-30 05971689 core:FurnitureFittingsToolsEquipment 2024-06-30 05971689 core:OtherPropertyPlantEquipment 2024-06-30 05971689 1 2024-06-30 05971689 2 2024-06-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 05971689

Cedar Clinic Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 June 2025

 

Cedar Clinic Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Financial Statements

4 to 11

 

Cedar Clinic Limited

Company Information

Directors

Dr N C Millhouse

Dr A Davidson

Registered office

9 Cedar Lane
Frimley
Surrey
GU16 7HT

Accountants

Jeremy Clark Accountants Ltd T/A AIMS
The Moat House
Sallow Lane
Wacton
Norwich
Norfolk
NR15 2UL

 

Cedar Clinic Limited

(Registration number: 05971689)
Balance Sheet as at 30 June 2025

Note

2025
£

2024
£

Fixed assets

 

Intangible assets

4

67,083

102,083

Tangible assets

5

8,349

11,630

 

75,432

113,713

Current assets

 

Stocks

6

714

817

Debtors

7

(113,322)

(80,503)

Cash at bank and in hand

 

313,982

234,140

 

201,374

154,454

Creditors: Amounts falling due within one year

8

(130,394)

(112,371)

Net current assets

 

70,980

42,083

Total assets less current liabilities

 

146,412

155,796

Creditors: Amounts falling due after more than one year

8

(129,916)

(144,458)

Provisions for liabilities

(1,734)

(2,477)

Net assets

 

14,762

8,861

Capital and reserves

 

Called up share capital

9

667

667

Retained earnings

14,095

8,194

Shareholders' funds

 

14,762

8,861

 

Cedar Clinic Limited

(Registration number: 05971689)
Balance Sheet as at 30 June 2025

For the financial year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 5 November 2025 and signed on its behalf by:
 

.........................................
Dr N C Millhouse
Director

.........................................
Dr A Davidson
Director

 

Cedar Clinic Limited

Notes to the Financial Statements for the Year Ended 30 June 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
9 Cedar Lane
Frimley
Surrey
GU16 7HT

These financial statements were authorised for issue by the Board on 5 November 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Cedar Clinic Limited

Notes to the Financial Statements for the Year Ended 30 June 2025

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

25% reducing balance basis

Furniture and fittings

25% reducing balance basis

Office equipment

33% straight line basis

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

Over 20 years, the estimated useful life

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Cedar Clinic Limited

Notes to the Financial Statements for the Year Ended 30 June 2025

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Cedar Clinic Limited

Notes to the Financial Statements for the Year Ended 30 June 2025

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 8 (2024 - 7).

 

Cedar Clinic Limited

Notes to the Financial Statements for the Year Ended 30 June 2025

4

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

At 1 July 2024

700,000

700,000

At 30 June 2025

700,000

700,000

Amortisation

At 1 July 2024

597,917

597,917

Amortisation charge

35,000

35,000

At 30 June 2025

632,917

632,917

Carrying amount

At 30 June 2025

67,083

67,083

At 30 June 2024

102,083

102,083

5

Tangible assets

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 July 2024

25,260

139,883

165,143

At 30 June 2025

25,260

139,883

165,143

Depreciation

At 1 July 2024

23,221

130,292

153,513

Charge for the year

748

2,533

3,281

At 30 June 2025

23,969

132,825

156,794

Carrying amount

At 30 June 2025

1,291

7,058

8,349

At 30 June 2024

2,039

9,591

11,630

6

Stocks

2025
£

2024
£

Other inventories

714

817

 

Cedar Clinic Limited

Notes to the Financial Statements for the Year Ended 30 June 2025

7

Debtors

Current

2025
£

2024
£

Trade debtors

3,240

5,545

Prepayments

-

1,200

Other debtors

(116,562)

(87,248)

 

(113,322)

(80,503)

 

Cedar Clinic Limited

Notes to the Financial Statements for the Year Ended 30 June 2025

8

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

Due within one year

 

Loans and borrowings

10

19,917

22,946

Trade creditors

 

1,630

2,256

Taxation and social security

 

63,833

50,401

Accruals and deferred income

 

1,704

1,704

Other creditors

 

43,310

35,064

 

130,394

112,371

Creditors: amounts falling due after more than one year

Note

2025
£

2024
£

Due after one year

 

Loans and borrowings

10

129,916

144,458

9

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary shares of £0.01 each

66,667

667

66,667

667

       

10

Loans and borrowings

Non-current loans and borrowings

2025
£

2024
£

Bank borrowings

129,916

144,458

Current loans and borrowings

2025
£

2024
£

Bank borrowings

19,917

22,946

Bank borrowings

 

Cedar Clinic Limited

Notes to the Financial Statements for the Year Ended 30 June 2025

Bank Loan is denominated in Sterling with a nominal interest rate of 7.03%, and the final instalment is due on 30 November 2034. The carrying amount at year end is £140,667 (2024 - £148,237).

CBILS Loan is denominated in Sterling with a nominal interest rate of 2.2%, and the final instalment is due on 31 May 2026. The carrying amount at year end is £9,167 (2024 - £19,167).